Skip to main content

. 1986 Sep;49(9):1090. doi: 10.1136/jnnp.49.9.1090-a

CSF and plasma levels of pro-opiomelanocortic-related peptides.

R P Iacona, R Sandyk

PMCID: PMC1029025 PMID: 3760904

1090

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Buchweitz E., Grandison L., Weiss H. R. Effect of morphine on regional cerebral oxygen consumption and supply. Brain Res. 1984 Jan 23;291(2):301–308. doi: 10.1016/0006-8993(84)91262-9. [DOI] [PubMed] [Google Scholar]
Claperon N., Durussel J. J., Rossignol P. Effect of naloxone on rat brain hypoxia. J Pharm Pharmacol. 1983 Oct;35(10):681–682. doi: 10.1111/j.2042-7158.1983.tb02868.x. [DOI] [PubMed] [Google Scholar]
Cutler J. R., Bredesen D. E., Edwards R., Simon R. P. Failure of naloxone to reverse vascular neurologic deficits. Neurology. 1983 Nov;33(11):1517–1518. doi: 10.1212/wnl.33.11.1517. [DOI] [PubMed] [Google Scholar]
Frederickson R. C., Norris F. H. Enkephalin-induced depression of single neurons in brain areas with opiate receptors--antagonism by naloxone. Science. 1976 Oct 22;194(4263):440–442. doi: 10.1126/science.10625. [DOI] [PubMed] [Google Scholar]
Nappi G., Facchinetti F., Bono G., Petraglia F., Sinforiani E., Genazzani A. R. CSF and plasma levels of pro-opiomelanocortin-related peptides in reversible ischaemic attacks and strokes. J Neurol Neurosurg Psychiatry. 1986 Jan;49(1):17–21. doi: 10.1136/jnnp.49.1.17. [DOI] [PMC free article] [PubMed] [Google Scholar]
Rothman S. M. Synaptic activity mediates death of hypoxic neurons. Science. 1983 Apr 29;220(4596):536–537. doi: 10.1126/science.6836300. [DOI] [PubMed] [Google Scholar]
Takeshita H., Michenfelder J. D., Theye R. A. The effects of morphine and N-allylnormorphine on canine cerebral metabolism and circulation. Anesthesiology. 1972 Dec;37(6):605–612. doi: 10.1097/00000542-197212000-00007. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES